Eli Lilly’s Zepbound Can Now Be Covered by Medicare to Treat Sleep Apnea | Global News Avenue

Welcome Lilly (Li Lai) Diet pill Zepbound may be covered by health insurance plans to treat sleep apnea upon receipt U.S. Food and Drug Administration (FDA) approved last month.

one Centers for Medicare and Medicaid Services spokesman told Investment Encyclopedia Thursday “Current Medicare Part D Medicaid coverage rules apply to Zepbound, which means it can be added to a Part D plan and covered by Medicare. It is estimated that millions of Americans suffer from obstructive sleep apnea, a sleep disorder.

Eli Lilly and Novo Nordisk, maker of Ozempic and Wegovynon-governmental organization) are testing their weight-loss drug’s ability to treat conditions that often accompany obesity, such as diabetes and sleep apnea. The change was first reported Wednesday CNBC.

The drug may also be covered by state-level Medicaid programs if it is used to treat sleep apnea and the drug manufacturer participates in the Medicaid Drug Rebate Program. About 780 companies participate in the rebate program, which covers drugs under Medicaid in exchange for companies paying rebates that are split between states and the federal government to offset drug costs.

Zepbound approved to treat sleep apnea After clinical trial Patients found taking the drug with or without tradition Sleep apnea treatments, such as masks, can reduce breathing interruptions during nighttime sleep.

this Biden administration November proposal including weight loss pills Medicare and Medicaid As a prescription treatment for obesity.